Abstract: Disclosed herein are compounds comprising dicarba-closo-dodecaborane. The compounds can be, for example, estrogen receptor beta (ER?) agonists. In some examples, the compounds can be selective ER? agonists. Also provided herein are methods of treating, preventing, or ameliorating cancer in a subject, suppressing tumor growth in a subject, treating an inflammatory disease in a subject, treating a neurodegenerative disease in a subject, treating a psychotropic disorder in a subject, or a combination thereof, by administering to a subject a therapeutically effective amount of one or more of the compounds or compositions described herein, or a pharmaceutically acceptable salt thereof.
Type:
Grant
Filed:
April 27, 2021
Date of Patent:
October 3, 2023
Assignees:
OHIO STATE INNOVATION FOUNDATION, INSTITUTE OF MOLECULAR GENETICS AS CR, V.V.I.
Inventors:
Werner Tjarks, Petr Bartunek, David Sedlak
Abstract: Disclosed herein are compounds comprising dicarba-closo-dodecaborane. The compounds can be, for example, estrogen receptor beta (ER?) agonists. In some examples, the compounds can be selective ER? agonists. Also provided herein are methods of treating, preventing, or ameliorating cancer in a subject, suppressing tumor growth in a subject, treating an inflammatory disease in a subject, treating a neurodegenerative disease in a subject, treating a psychotropic disorder in a subject, or a combination thereof by administering to a subject a therapeutically effective amount of one or more of the compounds or compositions described herein, or a pharmaceutically acceptable salt thereof.
Type:
Grant
Filed:
September 19, 2016
Date of Patent:
June 1, 2021
Assignees:
OHIO STATE INNOVATION FOUNDATION, INSTITUTE OF MOLECULAR GENETICS AS CR, V.V.I.
Inventors:
Werner Tjarks, Petr Bartunek, David Sedlak
Abstract: Disclosed herein are compounds comprising dicarba-closo-dodecaborane. The compounds can be, for example, estrogen receptor beta (ER?) agonists. In some examples, the compounds can be selective ER? agonists. Also provided herein are methods of treating, preventing, or ameliorating cancer in a subject, suppressing tumor growth in a subject, treating an inflammatory disease in a subject, treating a neurodegenerative disease in a subject, treating a psychotropic disorder in a subject, or a combination thereof by administering to a subject a therapeutically effective amount of one or more of the compounds or compositions described herein, or a pharmaceutically acceptable salt thereof.
Type:
Application
Filed:
September 19, 2016
Publication date:
September 20, 2018
Applicants:
OHIO STATE INNOVATION FOUNDATION, INSTITUTE OF MOLECULAR GENETICS AS CR, V.V.I.
Inventors:
Werner TJARKS, Petr BARTUNEK, David SEDLAK